The Advance of Personalized and Stratified Therapies in Bronchial Asthma: Phenotypes - Endotypes - Biomarkers.
Bronchial asthma (BA) is a chronic inflammatory condition with increasing incidence and prevalence worldwide. BA is currently the most prevalent chronic disease in pediatric patients. The majority of BA patients are therapeutically well controlled with guideline based anti-inflammatory therapies; however, there is also a clinically recognized proportion of patients who do not benefit from currently available medication for several reasons. This is the starting point for further investigation into the complexity of the inflammatory phenotype of BA. Recently, the heterogeneity in terms of cellular and molecular pathways underlying BA has been recognized and established. These different pathogenic mechanisms are defined as 'endotypes'. The best studied endotype so far is the association with T-helper type 2 (TH2) cell eosinophilic airway inflammation. Recently, a number of different therapeutic strategies have been clinically explored which target certain mediators of this pathway, including the interleukins IL-4, IL-5 and IL-13. It is now clear that patients with the TH2-endotype largely benefit from novel biologicals in this area. However, the challenge for diagnostics is to identify patients exhibiting this endotype, and this is the starting point for the search for new biomarkers. One biomarker that has recently been selected based on differential gene expression analysis, and which seems to be strongly associated with the TH2 endotype, is periostin. In this article we will provide a state of the art update on the definition of clinical phenotypes, pathogenetic endotypes and biomarker development for improving BA treatment.
Institute of Laboratory Medicine, Philipps-Universität Marburg, Germany.
Sebastian
S
Lauer
Institute of Laboratory Medicine, Philipps-Universität Marburg, Germany.
Harald
H
Renz
TH2 endotype; TH2 genotype; biomarker; bronchial asthma; periostin
Proc Natl Acad Sci U S A. 2007 Oct 2;104(40):15858-63
17898169
Nat Med. 2012 May 04;18(5):716-25
22561835
Allergy. 2012 Apr;67(4):451-61
22257145
Allergy. 2004 May;59(5):469-78
15080825
Clin Exp Allergy. 2012 May;42(5):650-8
22251060
J Exp Med. 2008 Feb 18;205(2):295-303
18208976
Am J Respir Crit Care Med. 2005 Sep 15;172(6):679-86
15947280
Am Rev Respir Dis. 1983 Nov;128(5):833-8
6556892
Nature. 2008 Jul 24;454(7203):463-9
18650917
J Immunol. 2011 Feb 1;186(3):1861-9
21187436
Am J Respir Crit Care Med. 2000 May;161(5):1720-45
10806180
Eur Respir J. 2013 Jun;41(6):1308-14
23060627
Cancer Res. 2002 Sep 15;62(18):5358-64
12235007
J Allergy Clin Immunol. 2005 Feb;115(2):233-42
15696076
Pediatr Pulmonol. 2004 Oct;38(4):321-8
15334510
Circulation. 2004 Sep 28;110(13):1806-13
15381649
J Allergy Clin Immunol. 2011 Sep;128(3):508-15.e1-2
21782230
J Allergy (Cairo). 2013;2013:602908
23878548
J Pediatr. 2003 Feb;142(2 Suppl):S45-6
12584520
J Infect. 2010 Oct;61(4):289-98
20638411
Science. 1998 Dec 18;282(5397):2261-3
9856950
Am J Respir Crit Care Med. 1998 Jun;157(6 Pt 1):1708-20
9620896
Am J Respir Crit Care Med. 2003 May 1;167(9):1239-43
12446273
Science. 1998 Dec 18;282(5397):2258-61
9856949
N Engl J Med. 2009 Mar 5;360(10):985-93
19264687
Immunol Rev. 2011 Jul;242(1):220-32
21682748
Cytokine. 2002 Sep 21;19(6):287-96
12421571
Clin Interv Aging. 2013;8:913-22
23885171
J Allergy Clin Immunol. 2006 Jul;118(1):98-104
16815144
Am J Physiol Gastrointest Liver Physiol. 2002 Feb;282(2):G226-32
11804843
N Engl J Med. 2010 Sep 23;363(13):1211-1221
20860503
J Allergy Clin Immunol. 1995 Apr;95(4):843-52
7722165
J Allergy Clin Immunol. 2010 Sep;126(3):498-504.e1-6
20816186
J Clin Invest. 2012 Jul;122(7):2590-600
22684102
Clin Exp Allergy. 1997 Mar;27(3):235-6
9088647
Am J Respir Crit Care Med. 2009 Sep 1;180(5):388-95
19483109
Br J Pharmacol. 1983 Feb;78(2):441-5
6299446
Treat Respir Med. 2005;4(5):309-16
16137188
J Allergy Clin Immunol. 2002 Mar;109(3):410-8
11897984
Am J Respir Crit Care Med. 2011 Nov 1;184(9):1007-14
21816938
Obesity (Silver Spring). 2014 Feb;22(2):356-62
23804543
Rev Mal Respir. 2003 Feb;20(1 Pt 1):95-103
12709638
Br J Pharmacol. 2003 Dec;140(7):1159-62
14597600
Allergy. 1998 Apr;53(4):346-52
9574875
Br Med J. 1930 Mar 1;1(3608):384-7
20775300
Am J Physiol Lung Cell Mol Physiol. 2001 Jan;280(1):L134-40
11133503
Immunity. 2001 Dec;15(6):985-95
11754819
N Engl J Med. 2011 Sep 22;365(12):1088-98
21812663
Eur Respir Rev. 2013 Mar 1;22(127):44-52
23457164
J Allergy Clin Immunol. 2010 May;125(5):1028-1036.e13
20398920
BMJ. 1989 Nov 18;299(6710):1259-60
2513902
Am J Physiol Lung Cell Mol Physiol. 2002 Mar;282(3):L520-8
11839548
Trends Cell Biol. 2000 Dec;10(12):542-50
11121747
Respir Med. 2012 Sep;106(9):1236-43
22703945
Am J Respir Crit Care Med. 2011 Apr 15;183(8):1007-14
21057005
N Engl J Med. 2005 Apr 14;352(15):1519-28
15829533
J Allergy Clin Immunol. 2007 May;119(5):1043-52; quiz 1053-4
17472810
Eur J Intern Med. 2009 Mar;20(2):114-24
19327598
Lancet. 2012 Aug 18;380(9842):651-9
22901886
Biochem J. 1993 Aug 15;294 ( Pt 1):271-8
8363580
J Allergy (Cairo). 2012;2012:163089
22577403
J Asthma. 2009 Aug;46(6):606-12
19657904
Circ Res. 2008 Apr 11;102(7):752-60
18296617
N Engl J Med. 2008 Nov 6;359(19):1985-94
18923164
J Allergy Clin Immunol. 2007 Jan;119(1):73-80
17208587
Nature. 2010 Jan 28;463(7280):540-4
20023630
Drugs Aging. 2000 Nov;17(5):385-97
11190418
J Immunol. 2011 Apr 15;186(8):4959-66
21402898
Proc Natl Acad Sci U S A. 2010 Aug 10;107(32):14170-5
20660732
Nat Med. 2007 Aug;13(8):962-9
17632525
Am J Respir Crit Care Med. 2000 Jun;161(6):2086-91
10852791
Med Klin (Munich). 2001 Jan 15;96(1):15-25
11210485
Proc Natl Acad Sci U S A. 2010 Jun 22;107(25):11489-94
20534524
Br J Dis Chest. 1977 Apr;71(2):73-86
861158
N Engl J Med. 1995 Jan 19;332(3):133-8
7800004
J Allergy Clin Immunol. 2005 Sep;116(3):586-93
16159628
J Allergy Clin Immunol. 2003 May;111(5):1032-40
12743568
J Allergy Clin Immunol. 2004 Mar;113(3):395-400
14758340
J Biol Chem. 2010 Apr 23;285(17):13294-303
20181949
N Engl J Med. 2009 Mar 5;360(10):973-84
19264686
Nat Med. 2012 Oct;18(10):1525-30
22961107
Clin Respir J. 2009 Oct;3(4):198-206
20298405
J Clin Invest. 1999 Mar;103(6):779-88
10079098
Biochem Pharmacol. 2011 Sep 15;82(6):567-85
21741955
Am J Respir Crit Care Med. 2010 Jun 1;181(11):1181-7
20516492
Cell Mol Life Sci. 2009 Jul;66(14):2219-30
19308325
Lancet. 2000 Oct 21;356(9239):1392-7
11052581
J Pediatr. 2003 Feb;142(2 Suppl):S34-8; discussion S38-9
12584518
J Allergy Clin Immunol. 2011 Jan;127(1):153-60, 160.e1-9
21211650
Am J Respir Crit Care Med. 1999 Sep;160(3):1001-8
10471631
Mech Dev. 2001 May;103(1-2):183-8
11335131
J Dtsch Dermatol Ges. 2007 Nov;5(11):1015-28
17976144
Mol Cell Biol. 2005 Dec;25(24):11131-44
16314533
J Allergy Clin Immunol. 1998 May;101(5):646-52
9600502
J Allergy Clin Immunol. 1997 May;99(5):657-65
9155833
Immunobiology. 2007;212(6):441-52
17544829
Nat Rev Immunol. 2008 Mar;8(3):218-30
18274559
J Allergy Clin Immunol. 2012 Sep;130(3):647-654.e10
22857879
Mucosal Immunol. 2008 Jul;1(4):289-96
19079190
Am J Physiol Lung Cell Mol Physiol. 2005 Mar;288(3):L576-84
15563687
Am J Respir Crit Care Med. 2008 Oct 1;178(7):667-72
18565953
Proc Natl Acad Sci U S A. 2007 Sep 11;104(37):14765-70
17766435
Thorax. 2007 Dec;62(12):1043-9
17356056
Rev Mal Respir. 2004 Nov;21(5 Pt 3):8S117-25
15803546
Clin Exp Allergy. 1995 Nov;25(11):1034-7
8581834
J Allergy. 1967 Nov;40(5):281-93
5235203
J Bone Miner Res. 1999 Jul;14(7):1239-49
10404027
Clin Exp Allergy. 1998 Nov;28 Suppl 5:52-66; discussion 90-1
9988448
Br J Pharmacol. 1983 Dec;80(4):699-702
6152829
Lancet. 2010 Sep 4;376(9743):803-13
20816547
Am J Respir Cell Mol Biol. 2012 May;46(5):677-86
22246863
J Immunol. 2005 May 1;174(9):5864-73
15843591
J Biol Chem. 2010 Jan 15;285(3):2028-39
19887451